Search
Search Results
##search.searchResults.foundPlural##
-
Osteolytic bone lesions – A rare presentation of AML M6.
1961PDF: 1090HTML: 7917Untitled: 202 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3741PDF: 1645HTML: 11557Figures Haase: 194 -
-
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7401PDF: 2412HTML: 1722Table 1.: 204Table 2.: 215Table 3.: 196Table 4.: 197 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1349HTML: 387PDF: 812 -
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
4062PDF: 1231HTML: 1952Table 1: 191 -
MIR-140 TARGETS LNCRNA DNAJC3-AS1 TO SUPPRESS CELL PROLIFERATION IN ACUTE MYELOID LEUKEMIA AML proliferation and MIR-140 LNCRNA DNAJC3-AS1 target.
1196PDF: 586HTML: 212 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3522PDF: 2392HTML: 1452 -
-
REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2305PDF: 978HTML: 7617Untitled: 272Fig2: 182Fig3: 166Fig4: 178 -
Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy
1174PDF: 748HTML: 1345Figure 1: 185Figure 2: 188 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
4038PDF: 1918HTML: 5220Table 1: 185 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
1996PDF: 756HTML: 3112 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2581PDF: 1603HTML: 2354Table1: 188 -
CHRONIC MYELOGENOUS LEUKEMIA (CML) IN THE ELDERLY
2869PDF: 1094HTML: 3029 -
CROCIN PROMOTES APOPTOSIS IN HUMAN EBV-TRANSFORMED B-LYMPHOCYTE VIA INTRINSIC PATHWAY CROCIN PROMOTES APOPTOSIS IN EBV-TRANSFORMED LCL
1246PDF: 480HTML: 135 -
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3291PDF: 1953HTML: 7472 -
EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA Empiric glycopeptide use in neutropenic fever
1435PDF: 1047HTML: 213 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
1770PDF: 963HTML: 140 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2150PDF: 1465HTML: 262 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
4057PDF: 3350HTML: 200 -
T-LYMPHOCYTES EXPRESSION OF TOLL-LIKE RECEPTORS 2 AND 4 IN ACUTE MYELOID LEUKEMIA PATIENTS WITH INVASIVE FUNGAL INFECTIONS Toll-like receptors 2 and 4 in Acute Myeloid Leukemia Patients with Invasive Fungal Infections
1759PDF: 697HTML: 333 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2783PDF: 1002HTML: 5516 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3564PDF: 876HTML: 6710 -
NEW STRATEGIES FOR STEM CELL MOBILIZATION
2390PDF: 849HTML: 2452 -
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1541PDF: 1193HTML: 186 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4074PDF: 1576HTML: 932 -
THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA
462PDF: 240HTML: 77







